rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    VALN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine
      Nov 10BenzingaVALN
      Why is Valneva stock climbing today?
      Nov 10Investing.comVALN
      Valneva rises as chikungunya vaccine antibodies persist in 94% after five years
      Nov 10Investing.comVALN
      Valneva Evaluates Next Steps for Bacterial Infection Vaccine Following Successful Phase 2 Studies
      Nov 9BenzingaVALN
      Why is Valneva stock rallying today?
      Nov 9Investing.comVALN
      Valneva reports positive phase 2 results for shigella vaccine
      Nov 9Investing.comVALN
      Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
      Oct 14Yahoo FinanceVALN
      Full Transcript: Valneva Q2 2026 Earnings Call - Valneva (NASDAQ:VALN)

      Valneva (NASDAQ:VALN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data and

      Oct 14BenzingaVALN
      UK Revokes Approval for Valneva's Chikungunya Shot - Valneva (NASDAQ:VALN)

      UK MHRA revokes Valneva’s IXCHIQ chikungunya vaccine authorization over traveler benefit-risk review. Minimal financial impact expected.

      Oct 8BenzingaVALN
      Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine
      Oct 8Yahoo FinanceVALN
      Valneva Says UK Revokes Chikungunya Virus Vaccine's Marketing Authorization; Shares Down Pre-Bell
      Oct 8Yahoo FinanceVALN
      Why is Valneva stock falling today?
      Oct 8Investing.comVALN
      Valneva stock falls after UK revokes Ixchiq vaccine approval
      Oct 8Investing.comVALN
      Valneva falls as UK revokes marketing authorization for chikungunya vaccine

      Valneva stock drops after UK MHRA revokes Ixchiq chikungunya vaccine authorization over safety concerns. Read more here.

      Oct 7Seeking AlphaVALN
      Why is Valneva stock sliding today?
      Oct 7Investing.comVALN
      UK revokes marketing authorization for Valneva’s IXCHIQ vaccine
      Oct 7Investing.comVALN
      Why is Valneva stock gaining today?
      Oct 7Investing.comVALN
      12 Health Care Stocks Moving In Wednesday's After-Market Session - Valneva (NASDAQ:VALN), Profound Medica

      Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million. Profound Medical (NASDAQ:PROF) stock rose 16.98% to $6.64.

      Oct 7BenzingaVALNCPHI
      Valneva ADRs fall as UK revokes IXCHIQ marketing authorization

      Investing.com -- Valneva SE ADRs (NASDAQ:VALN) fell 6.5% in after-hours trading Wednesday after the UK revoked the marketing authorization for its IXCHIQ chikungunya vaccine following a benefit-risk review.

      Oct 7Yahoo FinanceVALN
      Valneva Provides Update on IXCHIQ® in the United Kingdom

      Lyon (France), October 07, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ® for travelers by the United Kingdom’s (UK) Commission on Human Medicines (CHM), the UK marketing authorization for IXCHIQ® has been revoked by the Medicines and Healthcare products Regulatory Agency (MHRA). The decision was based on a review of previous safety data and was not associated with any newly identifi

      Oct 7Yahoo FinanceVALN
      VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
      Oct 7Yahoo FinanceVALN
      Valneva (VALN) Gets a Buy from H.C. Wainwright

      Detailed price information for Valneva Se ADR (VALN-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailVALN
      Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

      Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies’ experimental Lyme disease vaccine candidate, and will now begin the official review. For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French […]

      Sep 15Yahoo FinanceVALNPFE
      Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva

      Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Vaccines Market Distribution by Type of Vaccine API, Targeted Patient Population, Type of Vaccines, Route of Administration, and Key Geographical Region - Trends and Forecasts Till 2035" has been added to ResearchAndMarkets.com's offering. The global vaccines market is projected to increase from approximately USD 48 billion to USD 94 billion by 2030, representing a compound annual growth rate of about 11.9% during the forecast period. Market expans

      Sep 7Yahoo FinanceVALNEBS
      Pfizer (PFE) Starts EMA Review For Its Lyme Disease Vaccine

      Pfizer (NYSE:PFE) and Valneva announced that the European Medicines Agency has validated the Marketing Authorization Application for their Lyme disease vaccine candidate, PF-07307405. The validation starts the EMA regulatory assessment process for what could become a first in class Lyme disease vaccine for use in both North America and Europe. The application is supported by Phase 3 efficacy data, with the companies highlighting an unmet medical need in Lyme disease prevention. This move by...

      Aug 25Yahoo FinanceVALNPFE

      This is the newest page. Registered accounts read further back.